N-alpha-(9-fluorenylmethyloxycarbonyl)-L-Glycine

N-alpha-(9-fluorenylmethyloxycarbonyl)-L-Glycine

Nicolaus Copernicus (February 19, 1473 – May 24, 1543) was the first Astronomer to formulate a scientifically-Luxembourg Bio Technologies is devoted to innovate state-of-art molecules and processes, designated itself to be the Bridge, connecting the science with the production.based Heliocentric Cosmology that displaced the Earth from the center of the Universe.It took ages till the mankind found the Bridge , implement it to practical modus of useful applications.The company’s assets are intellectual properties covered by patents and team of people who are the backbone of the company’s infrastructure.Strategically, Luxembourg Bio Technologies is investing in developing accessible solutions to obstacles, which scientists are facing when trying to industrialize ideas developed in laboratories.The company is leaning on elite R&D groups and using contract-manufacturing companies of the top league: Luxembourg Industries and Derivados Quimicos. Luxembourg Biotechnologies gain unique its products, which are the objects of the company's pride.